APRI Profile of Cirrhotic Patients with Positive HBsAg

Introduction: Hepatitis B is a viral infection that has the potency to become chronic infection and cause serious complications such as liver cirrhosis and hepatocellular carcinoma. One of the tools in diagnosing hepatitis B or cirrhosis and predicting the prognosis is aspartate aminotransferase to...

Full description

Bibliographic Details
Main Authors: Nadya Husni, Leonita Anniwati, Lina Lukitasari
Format: Article
Language:English
Published: Fakultas Kedokteran Universitas Airlangga 2019-01-01
Series:Juxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Online Access:https://e-journal.unair.ac.id/JUXTA/article/view/10071
_version_ 1797954153309274112
author Nadya Husni
Leonita Anniwati
Lina Lukitasari
author_facet Nadya Husni
Leonita Anniwati
Lina Lukitasari
author_sort Nadya Husni
collection DOAJ
description Introduction: Hepatitis B is a viral infection that has the potency to become chronic infection and cause serious complications such as liver cirrhosis and hepatocellular carcinoma. One of the tools in diagnosing hepatitis B or cirrhosis and predicting the prognosis is aspartate aminotransferase to platelet ratio index (APRI). The purpose of this study is to evaluate the profile of APRI among cirrhotic patients with positive hepatitis B surface antigen (HBsAg). Method: This research was a descriptive observational study. The number of samples was 35 cirrhotic patients with positive HBsAg in RSUD Dr. Soetomo Surabaya from January-December 2017. Results: The majority of cirrhotic patients had >1,5 APRI score (48,57%). The most prevalent APRI score in Child A patients for first classification was 0,5 – 1,5 (5,71%) while for second classification was 0,7 – 1,5 (5,71%). The most prevalent APRI score in Child B patients for first classification was 0,5 – 1,5 (17,14%) while for second classification was 0,7 – 1,5 (11,43%). Most of Child C patients had >1,5 APRI score (22,86%). The majority of malignant degeneration patients also had >1,5 APRI score (14,29%). Conclusion: The majority of cirrhotic patients had >1,5 APRI score. In cirrhotic patients with Child A or B classification, the increase of APRI score was not as much as those with Child C or malignant degeneration classification. Keywords: Hepatitis B, cirrhosis, liver, hepatocellular carcinoma, APRI
first_indexed 2024-04-10T23:13:07Z
format Article
id doaj.art-30098b4505ff49be8e6bf0a89d815fc9
institution Directory Open Access Journal
issn 1907-3623
2684-9453
language English
last_indexed 2024-04-10T23:13:07Z
publishDate 2019-01-01
publisher Fakultas Kedokteran Universitas Airlangga
record_format Article
series Juxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
spelling doaj.art-30098b4505ff49be8e6bf0a89d815fc92023-01-13T03:44:03ZengFakultas Kedokteran Universitas AirlanggaJuxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga1907-36232684-94532019-01-01101343710.20473/juxta.V10I12019.34-377964APRI Profile of Cirrhotic Patients with Positive HBsAgNadya Husni0Leonita Anniwati1Lina LukitasariUniversitas AirlanggaUniversitas AirlanggaIntroduction: Hepatitis B is a viral infection that has the potency to become chronic infection and cause serious complications such as liver cirrhosis and hepatocellular carcinoma. One of the tools in diagnosing hepatitis B or cirrhosis and predicting the prognosis is aspartate aminotransferase to platelet ratio index (APRI). The purpose of this study is to evaluate the profile of APRI among cirrhotic patients with positive hepatitis B surface antigen (HBsAg). Method: This research was a descriptive observational study. The number of samples was 35 cirrhotic patients with positive HBsAg in RSUD Dr. Soetomo Surabaya from January-December 2017. Results: The majority of cirrhotic patients had >1,5 APRI score (48,57%). The most prevalent APRI score in Child A patients for first classification was 0,5 – 1,5 (5,71%) while for second classification was 0,7 – 1,5 (5,71%). The most prevalent APRI score in Child B patients for first classification was 0,5 – 1,5 (17,14%) while for second classification was 0,7 – 1,5 (11,43%). Most of Child C patients had >1,5 APRI score (22,86%). The majority of malignant degeneration patients also had >1,5 APRI score (14,29%). Conclusion: The majority of cirrhotic patients had >1,5 APRI score. In cirrhotic patients with Child A or B classification, the increase of APRI score was not as much as those with Child C or malignant degeneration classification. Keywords: Hepatitis B, cirrhosis, liver, hepatocellular carcinoma, APRIhttps://e-journal.unair.ac.id/JUXTA/article/view/10071
spellingShingle Nadya Husni
Leonita Anniwati
Lina Lukitasari
APRI Profile of Cirrhotic Patients with Positive HBsAg
Juxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
title APRI Profile of Cirrhotic Patients with Positive HBsAg
title_full APRI Profile of Cirrhotic Patients with Positive HBsAg
title_fullStr APRI Profile of Cirrhotic Patients with Positive HBsAg
title_full_unstemmed APRI Profile of Cirrhotic Patients with Positive HBsAg
title_short APRI Profile of Cirrhotic Patients with Positive HBsAg
title_sort apri profile of cirrhotic patients with positive hbsag
url https://e-journal.unair.ac.id/JUXTA/article/view/10071
work_keys_str_mv AT nadyahusni apriprofileofcirrhoticpatientswithpositivehbsag
AT leonitaanniwati apriprofileofcirrhoticpatientswithpositivehbsag
AT linalukitasari apriprofileofcirrhoticpatientswithpositivehbsag